Welcome to our dedicated page for Sleep Number SEC filings (Ticker: SNBR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Sleep Number Corporation (SNBR) SEC filings page provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. As a Minnesota-based sleep wellness and wellness technology company in the upholstered household furniture manufacturing industry, Sleep Number uses these filings to report on its financial condition, capital structure, governance, and material events affecting the business.
Investors can review periodic reports such as Forms 10-Q and 10-K, which contain detailed financial statements, management’s discussion of results, and information about the company’s vertically integrated, exclusive direct-to-consumer model for selling smart beds, mattresses, bases, bedding, pillows, and furniture. These reports also describe trends in net sales, margins, operating expenses, restructuring costs, and liquidity.
The filings page also highlights current reports on Form 8-K, where Sleep Number discloses material events. Recent 8-Ks have covered quarterly earnings releases, amendments to the company’s credit and security agreement, and leadership changes. For example, the company reported a Twelfth Amendment to its credit agreement that extends the maturity date, adjusts the revolving credit facility, revises leverage and liquidity covenants, and introduces a minimum EBITDA covenant and expanded addbacks in the consolidated EBITDA definition. Other 8-Ks have described interim and permanent chief financial officer appointments and board retirements.
Users interested in capital structure and covenant details can examine filings that explain leverage ratio thresholds, liquidity requirements, interest coverage ratios, and how consolidated EBITDA is calculated for covenant purposes. These documents provide insight into how Sleep Number is managing its turnaround, cost reductions, and compliance with revised covenants.
On Stock Titan, AI-powered tools summarize complex filings, highlight key terms, and help interpret items such as 10-K risk factors, 10-Q quarterly updates, and 8-K covenant amendments. This allows readers to quickly understand the implications of Sleep Number’s SEC disclosures, including how changes in its credit agreement, restructuring activities, and leadership transitions may affect the company’s financial flexibility and strategic plans.
Pacific Ridge Capital Partners, LLC filed a Schedule 13G reporting beneficial ownership of 1,145,612 shares of Sleep Number Corp common stock, representing 5.0% of the outstanding class as of the event date.
Pacific Ridge reports sole voting power over 704,330 shares and sole dispositive power over all 1,145,612 shares, with no shared voting or dispositive power. It certifies the Sleep Number shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the company.
FMR LLC has filed a Schedule 13G reporting beneficial ownership of 2,129,875.54 shares of Sleep Number Corp common stock, representing 9.3% of the outstanding class as of the event date. The filing also attributes the same 2,129,875.54 shares and 9.3% interest to Abigail P. Johnson, with sole dispositive power but no voting or shared dispositive power reported for her. FMR LLC reports sole voting power over 2,125,213 shares and confirms the holdings were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of Sleep Number.
Sleep Number Corporation entered into a three-year brand deal with Travis Kelce and TMK Enterprises LLC. The Athlete Parties will work with the company to promote the benefits of quality sleep and help expand its market reach.
Compensation to the Athlete Parties will include cash and a restricted stock unit award granted under Sleep Number’s 2020 Equity Incentive Plan, with vesting over three years. They also agreed to make open market purchases of Sleep Number common stock, aligning part of their interests with existing shareholders.
Sleep Number Corp executive vice president and chief financial officer Amy K. O'Keefe reported acquiring 69,742 shares of common stock in the form of restricted stock units on 12/15/2025. The award was recorded at a price of $0 per share.
Following this grant, she beneficially owns 69,742 shares directly, consisting of restricted stock units that will vest over time.
Sleep Number Corporation is registering 69,742 shares of common stock for issuance under a restricted stock unit inducement award to employee Amy K. O'Keefe. These shares will be delivered upon settlement of restricted stock units that are scheduled to be granted on December 15, 2025.
The award was approved by the company’s board of directors as an inducement material to the employee’s acceptance of employment, in accordance with Nasdaq Listing Rule 5635(c)(4). The inducement award will be issued outside of Sleep Number’s 2020 Equity Incentive Plan, and the filing also describes standard indemnification protections for directors and officers under Minnesota law and the company’s bylaws.
Sleep Number Corp (SNBR) insider equity update: Senior Vice President and Chief Supply Chain Officer Tanya C. Skogerboe reported equity activity effective 11/14/2025. On that date, 4,638 shares of Sleep Number common stock vested from restricted stock unit awards, and the reporting person covered the related estimated tax obligation in cash rather than by selling shares. Following the transaction, Skogerboe beneficially owned 47,877 shares of common stock directly and 2,517.4642 shares indirectly through a 401(k) plan, including 33,640 restricted stock units that vest over time.
Sleep Number Corporation (SNBR) filed an 8-K detailing its amended and extended credit agreement through 2027 and clarifying covenant terms and EBITDA definitions. The amendment raises near-term Net Leverage Ratio thresholds, including 5.25x for the quarter ended September 27, 2025, 4.50x for the quarter ending January 3, 2026, and 4.00x for each quarter thereafter.
The definition of Consolidated EBITDA now permits addbacks for approved pro forma cost actions implemented but not yet fully realized, while restructuring and other non-recurring addbacks are unchanged. The company reiterates 2025 adjusted EBITDA of about $70 million and, with roughly $40 million of structural changes, expects Consolidated EBITDA of about $110 million, supporting covenant compliance. Management plans to stabilize and modestly increase marketing in 2026 to back product launches, broaden consumer reach, and build on repeat demand.
Sleep Number (SNBR)49,746 common shares on 11/04/2025 at $0. The filing states these were Phantom Shares that converted to common stock when the reporting person ceased to be a Director. Following the transactions, the reporting person beneficially owned 98,085 shares.
The footnotes also note that 9,776 shares vested from restricted stock unit awards on 11/04/2025. The form indicates this will be the final reportable event based on recent activity.
Sleep Number (SNBR) reported a weak quarter with lower sales and losses. Net sales fell to $342.9 million, down 20% year over year, as lower volume and fewer stores weighed on results. Gross profit was $205.4 million with a 59.9% gross margin, slightly below last year’s 60.8%.
Operating loss was $40.3 million, driven in part by $39.2 million in restructuring costs. Net loss widened to $39.8 million, or $1.73 per diluted share. Sales and marketing fell in dollars but rose as a percentage of sales due to deleverage. R&D and G&A also declined year over year.
Liquidity remains tight. Cash was $1.3 million and borrowings under the credit facility were $579.5 million. For the first nine months, operating cash flow used $5.2 million and free cash flow used $17.0 million. On November 4, 2025, the company amended its credit agreement, extending maturity to December 3, 2027, adjusting pricing and covenants, and adding reporting requirements. The company was in compliance following the amendment. As of September 27, 2025, 22,790,000 common shares were outstanding.
Sleep Number (SNBR) amended its credit agreement, extending the maturity to December 3, 2027 and adjusting key terms. The revolving credit facility is reduced from $485 million to $475 million, and to $465 million on July 31, 2026. Pricing shifts to fixed grids: the Applicable Margin for Term SOFR Loans is 4.0% through December 31, 2026 and 4.25% starting January 1, 2027; the commitment fee is 0.50% through December 31, 2026 and 0.75% thereafter.
The amendment increases scheduled term-loan amortization by $1,250,000 per quarter beginning March 31, 2027 (aggregate $3,750,000). It terminates the accordion and tightens/clarifies covenants, including maximum Net Leverage Ratio stepping to 4.00x thereafter, a Liquidity minimum of $30 million until September 30, 2026 and $40 million monthly thereafter, refreshed Interest Coverage thresholds, and a new quarterly minimum EBITDA test. The company states it was in compliance following the amendment. Separately, Stephen L. Gulis, Jr. retired from the Board effective November 4, 2025.